J Nephropharmacol. 2023;12(2): e10604.
doi: 10.34172/npj.2023.10604

Scopus ID: 85161975312
  Abstract View: 1437
  PDF Download: 852


Association between type 2 diabetes mellitus and multiple myeloma: Fact or fiction

Ali Rastegar-Kashkouli 1 ORCID logo, Mohsen Jafari 1* ORCID logo, Saina Karami 2 ORCID logo, Pourya Yousefi 1 ORCID logo, Amir Mohammad Taravati 1* ORCID logo, Ashkan Khavaran 3 ORCID logo, Dordaneh Rastegar 4 ORCID logo, Mohammad Reza Jafari 1 ORCID logo, Seyedeh Yasaman Alemohammad 5 ORCID logo, Ghader Dargahi Abbasabad 6, Mohammad Shahbaz 7 ORCID logo, Mohammad Ebrahimi Kalan 8 ORCID logo

1 Nickan Research Institute, Isfahan, Iran
2 School of Pharmacy, University of Maryland, Baltimore, United States
3 Faculty of Medicine, University of Freiburg, Freiburg, Germany
4 Dr Maleknasab Pathology Lab, Shiraz, Iran
5 Robert Stemple College of Public Health and Social Work, Florida International University, Miami, Florida, United States
6 Applied Health Service Research, University of New Brunswick, Canada
7 Perinatal Science, University of Auckland, Auckland, New Zealand
8 Eastern Virginia Medical School, Norfolk, Virginia, United States
*Corresponding Authors: Mohsen Jafari, Email: dr.mohsenjafari97@gmail.com; Amir Mohammad Taravati, Email: Amir.taravati44@gmail.com


Multiple myeloma is a plasma cell cancer causing bone and marrow damage, resulting in hypercalcemia, anemia, and renal insufficiency. Diabetes mellitus occurs in 6-24% of multiple myeloma cases, associated with immunosuppression, inflammation, and lymphocyte dysfunction, possibly contributing to multiple myeloma development. Insulin and insulin-like growth factor-1 also contribute to multiple myeloma pathogenesis. The incidence of both multiple myeloma and diabetes mellitus is expected to rise due to the aging population, lifestyle changes, genetic predisposition, and improved diagnostic methods. Although the link between diabetes mellitus and hematological malignancy risk is less conclusive, insulin resistance and growth factors may promote tumor cell proliferation. Genetic variants linked to type 2 diabetes mellitus (T2DM) influence multiple myeloma risks. The insulin like growth factor 1 (IGF1) gene triggers malignant plasma cell proliferation. Additionally, poorly managed T2DM-induced acidosis creates a favorable environment for cancer cell growth, including multiple myeloma. T2DM and metabolic syndrome (MetS) increase multiple myeloma risks through insulin resistance, hyperinsulinemia, inflammation, and dyslipidemia. Inflammatory cytokines [interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1β (IL-1β)] contribute to insulin resistance, chronic inflammation, and multiple myeloma cell survival too. The coexistence of diabetes and multiple myeloma presents challenges in managing complications like neuropathy, nephropathy, and retinopathy. In conclusion, the association between T2DM and multiple myeloma has been established, with a discernible influence from distinct genetic variations. Notably, IL-6, TNF-alpha, and IL-1β exert significant influence on the development of insulin resistance and the proliferation of cancer cells, and also their viability. Consequently, the involvement of inflammatory cytokines, dyslipidemia, and IGF1 in the progression of MM among patients with T2DM and MetS is noteworthy.

Implication for health policy/practice/research/medical education:

According to our comprehensive review, there exists a correlation between T2DM and the onset and advancement of multiple myeloma, which can be attributed to a variety of distinct mechanisms.

Please cite this paper as: Rastegar-Kashkouli A, Jafari M, Karami S, Yousefi P, Taravati AM, Khavaran A, Rastegar D, Jafari MR, Alemohammad SY, Dargahi Abbasabad G, Shahbaz M, Ebrahimi Kalan M. Association between type 2 diabetes mellitus and multiple myeloma: fact or fiction. J Nephropharmacol. 2023;12(2):e10604. DOI: 10.34172/npj.2023.10604.

First Name
Last Name
Email Address
Security code

Abstract View: 1438

Your browser does not support the canvas element.

PDF Download: 852

Your browser does not support the canvas element.